Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor vaccination of healthy chickens 6-18 weeks of age by wing-web administration in the prevention of fowl pox.
LEARN MORE